Risperdal suits result in huge fines against Johnson & Johnson
For the past three years, pharmaceutical company Johnson & Johnson has been shelling out huge amounts of money in over 1,500 Risperdal lawsuits.
Risperdal is an antidepressant prescribed by health practitioners for bipolar and schizophrenia disorders. The downside of the drug is that it may cause an increased level of prolactin, which could result in breast enlargement among male patients. The FDA released advisory related to the risk of death in elderly patients, and uncontrollable abnormal movements around the shoulder, face, and limbs of patients.
Among the damages incurred are three trials for not sufficiently cautioning patients about the risks of taking the drug. In November 2013, Johnson & Johnson was fined $2.2 billion because of civil and criminal claims. The company also suffered marketing claims settlements amounting to $158 million, $124 million, and $180 million in Texas, South Carolina, and D.C., respectively.
At Williams Kherkher, we recognize the dangers of pharmaceuticals, especially Risperdal. Contact us at (888) 220-0640 to learn more about your legal options.